E

EryDel S.p.A.

25 employees

Erydel develops technology for drug delivery of pharmacological agents through red blood cells.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Health Care

rare disease

science and technology

orphan drugs

ataxia telangiectasia

enzyme replacement

Pharmaceutical

platform

red blood cell

biotech

Date founded

2007

FAQ